Array Biopharma (NASDAQ:ARRY) released its earnings data on Tuesday. The company reported ($0.21) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.22) by $0.01. The company had revenue of $6.07 million for the quarter, compared to the consensus estimate of $6.35 million. During the same quarter in the prior year, the company posted ($0.13) earnings per share. The company’s quarterly revenue was … Continue reading Today’s Watch List: Array BioPharma, Inc. (NASDAQ:ARRY), Fairchild Semiconductor International Inc. (NASDAQ:FCS), Flowserve Corp. (NYSE:FLS), Red Hat, Inc. (NYSE:RHT), JBSS